Wealthcare Advisory Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $265K | Sell |
3,834
-452
| -11% | -$31.2K | 0.01% | 838 |
|
|
2025
Q1 | $298K | Sell |
4,286
-21,139
| -83% | -$1.47M | 0.01% | 747 |
|
|
2024
Q4 | $2.19M | Buy |
25,425
+10,839
| +74% | +$932K | 0.06% | 253 |
|
|
2024
Q3 | $1.74M | Sell |
14,586
-1,138
| -7% | -$136K | 0.05% | 296 |
|
|
2024
Q2 | $2.24M | Buy |
15,724
+1,471
| +10% | +$210K | 0.07% | 219 |
|
|
2024
Q1 | $1.83M | Buy |
14,253
+3,990
| +39% | +$512K | 0.06% | 247 |
|
|
2023
Q4 | $1.06M | Buy |
10,263
+607
| +6% | +$62.8K | 0.04% | 305 |
|
|
2023
Q3 | $878K | Buy |
9,656
+4,934
| +104% | +$449K | 0.04% | 303 |
|
|
2023
Q2 | $382K | Buy |
4,722
+604
| +15% | +$48.9K | 0.02% | 509 |
|
|
2023
Q1 | $328K | Sell |
4,118
-466
| -10% | -$37.1K | 0.01% | 559 |
|
|
2022
Q4 | $310K | Buy |
+4,584
| New | +$310K | 0.01% | 527 |
|
|
2021
Q2 | – | Sell |
-3,108
| Closed | -$105K | – | 1406 |
|
|
2021
Q1 | $105K | Buy |
+3,108
| New | +$105K | 0.01% | 654 |
|
|
2020
Q2 | – | Sell |
-1,730
| Closed | -$52K | – | 1026 |
|
|
2020
Q1 | $52K | Hold |
1,730
| – | – | 0.01% | 507 |
|
|
2019
Q4 | $50K | Hold |
1,730
| – | – | 0.01% | 550 |
|
|
2019
Q3 | $45K | Buy |
1,730
+2
| +0.1% | +$52 | 0.01% | 559 |
|
|
2019
Q2 | $44K | Buy |
1,728
+744
| +76% | +$18.9K | 0.01% | 542 |
|
|
2019
Q1 | $26K | Hold |
984
| – | – | ﹤0.01% | 601 |
|
|
2018
Q4 | $23K | Sell |
984
-642
| -39% | -$15K | ﹤0.01% | 593 |
|
|
2018
Q3 | $38K | Buy |
1,626
+2
| +0.1% | +$47 | 0.01% | 533 |
|
|
2018
Q2 | $37K | Buy |
1,624
+238
| +17% | +$5.42K | 0.01% | 525 |
|
|
2018
Q1 | $34K | Hold |
1,386
| – | – | 0.01% | 466 |
|
|
2017
Q4 | $37K | Buy |
1,386
+1,126
| +433% | +$30.1K | 0.01% | 426 |
|
|
2017
Q3 | $6K | Buy |
+260
| New | +$6K | ﹤0.01% | 620 |
|